Drug profile · INN
azathioprine sodium
AZATHIOPRINE
azathioprine sodium (AZATHIOPRINE) is a amidophosphoribosyltransferase inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — azathioprine sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 11
- Data quality
- 0.84
Quick answer
azathioprine sodium (AZATHIOPRINE) is a amidophosphoribosyltransferase inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Amidophosphoribosyltransferase inhibitor
Primary target: Amidophosphoribosyltransferase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is azathioprine sodium?
azathioprine sodium (AZATHIOPRINE) is a amidophosphoribosyltransferase inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for azathioprine sodium?
AZATHIOPRINE is a marketed brand name for azathioprine sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of azathioprine sodium?
azathioprine sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.